drugset / Trial / NCT01350037
Alfentanil Versus Remifentanil in Patient-controlled Sedation During Endoscopic Retrograde Cholangiopancreatography (ERCP)
RandomizedParallel-groupTriple-blindTreatment
Summary
Self-administration of propofol and opioid mixture by the patient him- or herself (patient-controlled sedation, PCS) could be successful alternative to the anesthesiologists-managed deep sedation during endoscopic retrograde cholangiopancreatography (ERCP). However, it is not known which opioid would be the most suitable for PCS. The aim of this double-blind study was to compare remifentanil and alfentanil in PCS during ERCP.
Timeline
- Start
- 2009-06
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Alfentanil | Other / unclassified | 0.04 mg/ml | Other |
| Comparator | Alfentanil | Other / unclassified | 0.08 mg/ml | Other |
| Comparator | Remifentanil | Small molecule | — | Intravenous |